Clinical and laboratory features associated with myeloperoxidase expression in pediatric B‐lymphoblastic leukemia

Abstract

In our study cohort, MPO+ B-ALL showed minimal residual disease persistence less often after induction chemotherapy but otherwise had similar clinical outcomes to MPO- B-ALL, with similar rates of additional myeloid antigen aberrancy.